Inhibition of MiRNA-222-3p Relieves Staphylococcal Enterotoxin B-Induced Liver Inflammatory Injury by Upregulating Suppressors of Cytokine Signaling 1
Overview
Authors
Affiliations
Purpose: Staphylococcal enterotoxin B (SEB) has been well-documented to induce liver injury. miRNA-222-3p (miR-222-3p) was implicated in SEB-induced lung injury and several liver injuries. This study aimed to explore the role of miR-222-3p in SEB-induced liver injury.
Materials And Methods: Expression of miR-222-3p and suppressors of cytokine signaling 1 (SOCS1) was detected using real-time quantitative PCR and western blot. Liver injury was determined by levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and inflammatory cytokines, numbers of infiltrating mononuclear cells using AST/ALT assay kit, enzyme-linked immunosorbent assay (ELISA), and hematoxylin-eosin staining, respectively. Target binding between miR-222-3p and SOCS1 was predicted on targetScan software, and confirmed by luciferase reporter assay.
Results: SEB induced liver injury in D-galactosamine (D-gal)-sensitized mice, as demonstrated by increased serum levels of AST and ALT, elevated release of interferon-gamma (INF-γ), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-2, and promoted infiltrating immune cells into liver. Expression of miR-222-3p was dramatically upregulated, and SOCS1 was downregulated in SEB-induced liver injury both in mice and splenocytes. Moreover, miR-222-3p knockout (KO) mice exhibited alleviated liver injury accompanied with SOCS1 upregulation. Besides, splenocytes under SEB challenge released less INF-γ, TNF-α, IL-6, and IL-2 during miR-222-3p knockdown. Mechanically, SOCS1 was targeted and downregulated by miR-222-3p. Upregulation of SOCS1 attenuated INF-γ, TNF-α, IL-6, and IL-2 release in SEB-induced splenocytes; downregulation of SOCS1 could block the suppressive role of miR-222-3p knockdown in SEB-induced splenocytes.
Conclusion: Inhibition of miR-222-3p relieves SEB-induced liver inflammatory injury by upregulating SOCS1, thereby providing the first evidence of miR-222-3p in SEB-induced liver injury.
Wang X, Ji H, Yang Y, Zhang D, Kong X, Li X J Immunol Res. 2024; 2024:8273732.
PMID: 39359694 PMC: 11446618. DOI: 10.1155/2024/8273732.
Jie R, Qian J, Tang Y, Li Y, Xu M, Zhao X Diabetes Metab Syndr Obes. 2023; 16:2419-2432.
PMID: 37602205 PMC: 10439793. DOI: 10.2147/DMSO.S410986.
Li J, Sun G, Ma H, Wu X, Li C, Ding P Front Cardiovasc Med. 2022; 9:971543.
PMID: 36204577 PMC: 9530044. DOI: 10.3389/fcvm.2022.971543.
Xia F, Bo W, Ding J, Yu Y, Wang J Turk J Gastroenterol. 2022; 33(11):934-944.
PMID: 35946880 PMC: 9797778. DOI: 10.5152/tjg.2022.21769.